STOCK TITAN

Doximity (DOCS) SEC Filings, Jul-Aug 2025

DOCS NYSE

Doximity filings document financial results, material events, governance actions, and capital-structure details for the operator of a digital platform for U.S. medical professionals. Recent Form 8-K disclosures cover quarterly results and related exhibits, finance and legal leadership changes, Regulation FD updates, and annual-meeting voting outcomes.

The company's regulatory record also includes shareholder voting matters tied to its Class A and Class B common stock structure, director elections, auditor ratification, material agreements, and other security-holder matters. These filings describe how Doximity reports operating performance, governance changes, voting mechanics, and formal public-company events.

Rhea-AI Summary

Benjamin Regina M., a director of Doximity, Inc. (DOCS), reported transactions dated 08/08/2025. The Form 4 shows the conversion of 5,000 shares of Class B Common Stock into Class A Common Stock and the sale of 5,000 shares of Class A Common Stock at $63 per share. The sale occurred automatically under a Rule 10b5-1 trading plan adopted February 26, 2025.

Following the reported transactions the form lists the Reporting Person's beneficial ownership as 16,618 shares of Class A Common Stock. The filing also discloses derivative/option positions, with one line showing 361,138 derivative-equivalent shares beneficially owned after the reported transactions. The Form 4 is signed by an attorney-in-fact on 08/11/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.02%
Tags
insider
-
Rhea-AI Summary

Form 144 filed for proposed sale of common stock. The notice reports a proposed sale of 5,000 shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $315,000 and states total shares outstanding of 187,299,459. The securities are shown as acquired on 08/08/2025 by a stock option exercise from the issuer and paid in cash.

The filing also discloses prior sales by the same account in the past three months: 5,000 shares sold on 07/11/2025 for $300,200 and 10,000 shares sold on 06/25/2025 for $600,000. The signer attests they have no undisclosed material information as of the notice.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.13%
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.71%
Tags
current report
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.35%
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
other
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.24%
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.24%
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.01%
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.59%
Tags
other

FAQ

How many Doximity (DOCS) SEC filings are available on StockTitan?

StockTitan tracks 124 SEC filings for Doximity (DOCS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Doximity (DOCS)?

The most recent SEC filing for Doximity (DOCS) was filed on August 11, 2025.